Alzheimer’s disease drug
C7048
concept
An Alzheimer’s disease drug is a pharmacological agent designed to prevent, slow, or alleviate the cognitive and functional decline associated with Alzheimer’s pathology, typically by targeting amyloid, tau, neurotransmitter systems, or related neurodegenerative mechanisms.
All labels observed (3)
| Label | Occurrences |
|---|---|
| NMDA receptor antagonist | 2 |
| Alzheimer’s disease drug canonical | 1 |
| Alzheimer’s disease therapy candidate | 1 |
Description generation (CDg)
The one-sentence description above was generated by prompting gpt-5.1 with the class name and this instruction.
Instruction
generate a one-sentence description for a given conceptual class. # Response Format Return only the sentence: "Description: [one-sentence description of the conceptional class]"
Input
Class: Alzheimer’s disease drug
Generated description
An Alzheimer’s disease drug is a pharmacological agent designed to prevent, slow, or alleviate the cognitive and functional decline associated with Alzheimer’s pathology, typically by targeting amyloid, tau, neurotransmitter systems, or related neurodegenerative mechanisms.
Instances (4)
| Instance | Via concept surface |
|---|---|
|
memantine
surface form:
Memantine
|
NMDA receptor antagonist |
| amantadine | NMDA receptor antagonist |
| Leqembi | — |
| bapineuzumab | Alzheimer’s disease therapy candidate |